Preview Mode Links will not work in preview mode

Jul 8, 2024

Featuring perspectives from Dr Rebecca S Heist, Dr Luis Paz-Ares and Dr Jacob Sands, moderated by Dr Sands, including the following topics:

  • Introduction (0:00)
  • Integration of Antibody-Drug Conjugates (ADCs) into the Care of Patients with Non-Small Cell Lung Cancer (NSCLC) and HER2 Alterations — Dr Paz-Ares (1:28)


Jun 21, 2024

Featuring perspectives from Dr Jonathan W Goldman, Dr Corey J Langer, Dr Joel W Neal, Dr Zofia Piotrowska, Dr Joshua K Sabari and Dr Helena Yu, moderated by Dr Yu, including the following topics:

  • Introduction (0:00)
  • Contemporary Care for Patients with Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) with an...


Jun 12, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer | Faculty Presentation 2: Therapeutic Approaches for Patients with NSCLC and Other Actionable Genomic Alterations — Justin F Gainor, MD

CME information and select...


Jun 12, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer | Faculty Presentation 1: Management of Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Karen Reckamp, MD, MS

CME information and select...


Jun 12, 2024

Featuring perspectives from Dr Justin F Gainor and Dr Karen Reckamp, including the following topics:

  • Introduction: Bringing Research into Practice (0:00)
  • EGFR Activating Mutations (14:01)
  • Exon 20 Insertion Mutations (38:06)
  • MET Exon 14 Alterations (41:49)
  • HER2 Mutations and Overexpression (50:27)

CME information and...